It is considered essential for longitudinal bone growth, skeletal maturation, and bone mass acquisition during growth performance and maintenance, whereas lower serum IGF-1 levels are associated with the prevalence of fractures and increased risk of osteoporosis in postmenopausal women [29]. The gene discussed is IGF1; the disease is osteoporosis.